SZ 469 (Glimepiride and Pioglitazone Hydrochloride 4 mg / 30 mg (base))
Pill with imprint SZ 469 is White, Elliptical/Oval and has been identified as Glimepiride and Pioglitazone Hydrochloride 4 mg / 30 mg (base). It is supplied by Sandoz Inc.
Glimepiride/pioglitazone is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Glimepiride/pioglitazone 4 mg / 30 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).
Images for SZ 469
Glimepiride and Pioglitazone Hydrochloride
- Imprint
- SZ 469
- Strength
- 4 mg / 30 mg (base)
- Color
- White
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- Antidiabetic combinations
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sandoz Inc.
- National Drug Code (NDC)
- 00781-5635
- Inactive Ingredients
-
croscarmellose sodium,
lactose monohydrate,
magnesium stearate,
polysorbate 80,
microcrystalline cellulose
Note: Inactive ingredients may vary.
More about glimepiride / pioglitazone
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (2)
- Imprints, shape & color data
- Pricing & coupons
- En español
- Drug class: antidiabetic combinations
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.